Analyst Rami Katkhuda from LifeSci Capital maintained a Buy rating on the stock and has a $45.00 price target. Pick the best stocks and maximize your portfolio: Discover top-rated stocks from ...

Featuring around 70 artworks from important European collections, this landmark exhibition will follow Hugo’s preoccupation with drawing, from his early caricatures and travel drawings to his dramatic ...

In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Akero Therapeutics (AKRO – Research Report), with a price target of $60.00. Rami Katkhuda has given his ...

If you want to study at the University of the Year 2024 (Whatuni Student Choice Awards), ranked 5th in the UK for job prospects (Student Crowd Awards 2024), apply now to start in September 2025. We ...